RxDoctor Payments Data

Heather Rahim, NP

Adult Health · Wheat Ridge, CONPI 1679977284

Payments from drug & device makers

$1,775in general payments, 2019–2025

Across 60 payments — averaging $29.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$428
  • Novartis$203
  • Amgen$176
  • Otsuka America Pharmaceutical, Inc.$143
  • Vifor Pharma, Inc.$130
  • GSK$122
  • plus $573 from 12 others

What the payments were for

  • Food & beverage$1,775100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,775 in reported general payments places this provider in the 80th percentile of 430 adult health providers in Colorado.

See all adult health providers in Colorado

Medicare billing

Part B allowed, 2024
$21,345
Medicare patients
127
Services billed
385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin51$40,446
LokelmaSodium Zirconium Cyclosilicate32$37,452
FarxigaDapagliflozin Propanediol37$33,722
KerendiaFinerenone15$30,506
EliquisApixaban16$19,371
Sevelamer Carbonate34$8,741
Calcium Acetate34$5,013
Midodrine Hcl33$2,191
Bumetanide18$1,325
Carvedilol83$1,016
Lidocaine-PrilocaineLidocaine/Prilocaine15$1,007
Hydralazine Hcl66$851
Losartan Potassium101$784
Amlodipine Besylate84$670
Lisinopril75$670

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLokelma, Farxiga$428$71,17469 claims
Boehringer IngelheimJardiance$40$40,44651 claims
BayerKerendia$99$30,50615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 430 adult health providers in Colorado.

Other adult health in Wheat Ridge

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →